Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$483K Sell
1,335
-11
-0.8% -$3.77K 0.1% 142
2026
Q1
$474K Buy
1,346
+1
+0.1% +$356 0.11% 134
2025
Q4
$440K Hold
1,345
0.1% 137
2025
Q3
$380K Sell
1,345
-46
-3% -$13.3K 0.09% 148
2025
Q2
$388K Hold
1,391
0.1% 147
2025
Q1
$433K Sell
1,391
-122
-8% -$36K 0.11% 141
2024
Q4
$394K Sell
1,513
-50
-3% -$14.8K 0.1% 145
2024
Q3
$504K Sell
1,563
-34
-2% -$11.1K 0.13% 134
2024
Q2
$499K Sell
1,597
-81
-5% -$23.8K 0.13% 131
2024
Q1
$477K Sell
1,678
-158
-9% -$46.2K 0.13% 135
2023
Q4
$529K Sell
1,836
-454
-20% -$124K 0.15% 126
2023
Q3
$615K Sell
2,290
-90
-4% -$22.5K 0.18% 116
2023
Q2
$528K Sell
2,380
-55
-2% -$12.8K 0.15% 131
2023
Q1
$589K Sell
2,435
-34
-1% -$8.35K 0.18% 119
2022
Q4
$648K Sell
2,469
-47
-2% -$12.6K 0.2% 114
2022
Q3
$567K Sell
2,516
-43
-2% -$10.4K 0.18% 121
2022
Q2
$623K Sell
2,559
-134
-5% -$32.8K 0.18% 124
2022
Q1
$651K Sell
2,693
-4
-0.1% -$919 0.16% 131
2021
Q4
$606K Sell
2,697
-4,207
-61% -$888K 0.15% 133
2021
Q3
$1.68M Hold
6,904
0.45% 69
2021
Q2
$1.68M Buy
+6,904
New +$1.7M 0.45% 69

Other funds holding AMGN

Bank of New Hampshire's AMGN Position: Q2 2026 in Review

Bank of New Hampshire reduced its Amgen (AMGN) stake by 0.82% in Q2 2026, selling an estimated $3.77K and leaving 1,335 shares worth $483K. The position accounts for 0.1% of the portfolio, ranked #142.

Bank of New Hampshire first reported a position in AMGN in Q2 2021 and has held it in 21 quarters since. The position peaked at $1.68M in Q3 2021. 1,635 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Bank of New Hampshire held 1,335 shares of Amgen worth $483K as of Q2 2026.
  • Bank of New Hampshire sold 11 Amgen shares in Q2 2026, an estimated $3.77K.
  • Amgen made up 0.1% of Bank of New Hampshire's portfolio in Q2 2026, its #142 holding.
  • Bank of New Hampshire first reported a position in Amgen in Q2 2021 and has held it in 21 quarters since.
  • Bank of New Hampshire's Amgen position peaked at $1.68M in Q3 2021.
  • 1,635 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Bank of New Hampshire's 13F filing for Q2 2026, filed 14 Jul 2026.